• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

从肝硬化发展到肝细胞癌过程中的染色体等位基因失衡。

Chromosomal allelic imbalance evolving from liver cirrhosis to hepatocellular carcinoma.

作者信息

Yeh S H, Chen P J, Shau W Y, Chen Y W, Lee P H, Chen J T, Chen D S

机构信息

Hepatitis Research Center, National Taiwan University Hospital, Taipei, Taiwan.

出版信息

Gastroenterology. 2001 Sep;121(3):699-709. doi: 10.1053/gast.2001.27211.

DOI:10.1053/gast.2001.27211
PMID:11522754
Abstract

BACKGROUND & AIMS: Cirrhotic nodules have long been assumed to be the precancerous lesions of hepatocellular carcinoma (HCC). We thus investigated the allelic imbalance (AI) in cirrhotic nodules to define the genetic aberrations in early hepatocarcinogenesis.

METHODS

One hundred eighty cirrhotic nodules from 7 female patients with HCC were collected by microdissection. Their clonality nature was assessed by examining the X chromosome methylation pattern. AI in monoclonal cirrhotic nodules and the corresponding HCCs were analyzed with microsatellite polymorphic markers.

RESULTS

One hundred one out of 180 nodules (56.1%) were monoclonal and the average fractional AI (FAI) was 21%, lower than the 40% in HCC. Their overall AI patterns differed significantly from that in HCC (P < 0.001) with FAI on 2q, 4q, 8p, and Xq higher than the mean value. Comparison of FAI in nodules (stratified by increasing total AI events) further revealed a progressive increase of FAI on 4q, 8p, and Xq. In contrast, FAI on 1p, 13q, 16q, and 17p were low in nodules but rose above the mean only in HCC.

CONCLUSIONS

About half of the cirrhotic nodules are monoclonal and already have chromosome aberrations. AI on 4q, 8p, and Xq may be the earlier mutations, whereas AI on 1p, 13q, 16q, and 17p occurs late in hepatocarcinogenesis.

摘要

背景与目的

长期以来,肝硬化结节一直被认为是肝细胞癌(HCC)的癌前病变。因此,我们研究了肝硬化结节中的等位基因失衡(AI),以确定肝癌早期发生过程中的基因畸变。

方法

通过显微切割收集了7例女性HCC患者的180个肝硬化结节。通过检查X染色体甲基化模式评估其克隆性。使用微卫星多态性标记分析单克隆肝硬化结节及相应HCC中的AI。

结果

180个结节中有101个(56.1%)为单克隆,平均分数AI(FAI)为21%,低于HCC中的40%。它们的总体AI模式与HCC中的显著不同(P < 0.001),2q、4q、8p和Xq上的FAI高于平均值。对结节中FAI(按总AI事件增加分层)的比较进一步显示,4q、8p和Xq上 的FAI逐渐增加。相比之下,1p、13q、16q和17p上的FAI在结节中较低,但仅在HCC中升至平均值以上。

结论

约一半的肝硬化结节是单克隆的,并且已经存在染色体畸变。4q、8p和Xq上的AI可能是较早的突变,而1p、13q、16q和17p上的AI发生在肝癌发生的后期。

相似文献

1
Chromosomal allelic imbalance evolving from liver cirrhosis to hepatocellular carcinoma.从肝硬化发展到肝细胞癌过程中的染色体等位基因失衡。
Gastroenterology. 2001 Sep;121(3):699-709. doi: 10.1053/gast.2001.27211.
2
Chromosomal instability and human hepatocarcinogenesis.染色体不稳定性与人类肝癌发生
Histol Histopathol. 2003 Jul;18(3):897-909. doi: 10.14670/HH-18.897.
3
Molecular cytogenetic evaluation of virus-associated and non-viral hepatocellular carcinoma: analysis of 26 carcinomas and 12 concurrent dysplasias.病毒相关性和非病毒性肝细胞癌的分子细胞遗传学评估:26例癌和12例并发发育异常的分析
J Pathol. 2000 Oct;192(2):207-15. doi: 10.1002/1096-9896(2000)9999:9999<::AID-PATH690>3.0.CO;2-#.
4
Fractional allelic loss in non-end-stage cirrhosis: correlations with hepatocellular carcinoma development during follow-up.
Hepatology. 2000 Apr;31(4):846-50. doi: 10.1053/he.2000.5790.
5
Varying etiologies lead to different molecular changes in Australian and South African hepatocellular carcinomas.不同的病因导致澳大利亚和南非肝细胞癌出现不同的分子变化。
Int J Oncol. 2009 Nov;35(5):1081-9. doi: 10.3892/ijo_00000423.
6
Comprehensive allelotyping of well-differentiated human hepatocellular carcinoma with semiquantitative determination of chromosomal gain or loss.对高分化人肝细胞癌进行全面的等位基因分型,并对染色体的增减进行半定量测定。
Genes Chromosomes Cancer. 2002 Dec;35(4):329-39. doi: 10.1002/gcc.10126.
7
Dominance of functional androgen receptor allele with longer CAG repeat in hepatitis B virus-related female hepatocarcinogenesis.在乙型肝炎病毒相关的女性肝癌发生中,具有较长CAG重复序列的功能性雄激素受体等位基因的优势。
Cancer Res. 2002 Aug 1;62(15):4346-51.
8
Genotype stability and clonal evolution of hepatocellular carcinoma assessed by autopsy-based genome-wide microsatellite analysis.通过基于尸检的全基因组微卫星分析评估肝细胞癌的基因型稳定性和克隆进化。
Cancer Genet Cytogenet. 2005 Sep;161(2):164-9. doi: 10.1016/j.cancergencyto.2005.02.011.
9
Molecular changes in hepatocellular dysplastic nodules on microdissected liver biopsies.经显微切割的肝脏活检组织中肝细胞发育异常结节的分子变化
Hepatology. 2000 Nov;32(5):942-6. doi: 10.1053/jhep.2000.18425.
10
Allelic imbalance regions on chromosomes 8p, 17p and 19p related to metastasis of hepatocellular carcinoma: comparison between matched primary and metastatic lesions in 22 patients by genome-wide microsatellite analysis.与肝细胞癌转移相关的8号染色体短臂、17号染色体短臂和19号染色体短臂上的等位基因不平衡区域:通过全基因组微卫星分析对22例患者配对的原发性和转移性病变进行比较
J Cancer Res Clin Oncol. 2003 May;129(5):279-86. doi: 10.1007/s00432-002-0407-5. Epub 2003 May 7.

引用本文的文献

1
Custom gene expression panel for evaluation of potential molecular markers in hepatocellular carcinoma.用于评估肝细胞癌潜在分子标志物的定制基因表达谱。
BMC Med Genomics. 2022 Nov 7;15(1):235. doi: 10.1186/s12920-022-01386-7.
2
Nitrosative Stress and Human Disease: Therapeutic Potential of Denitrosylation.硝化应激与人类疾病:去硝化作用的治疗潜力。
Int J Mol Sci. 2021 Sep 10;22(18):9794. doi: 10.3390/ijms22189794.
3
Progesterone receptor membrane component 1 as a potential prognostic biomarker for hepatocellular carcinoma.
孕激素受体膜成分 1 作为肝细胞癌潜在的预后生物标志物。
World J Gastroenterol. 2018 Mar 14;24(10):1152-1166. doi: 10.3748/wjg.v24.i10.1152.
4
Selective Retention of an Inactive Allele of the DKK2 Tumor Suppressor Gene in Hepatocellular Carcinoma.肝细胞癌中DKK2肿瘤抑制基因失活等位基因的选择性保留
PLoS Genet. 2016 May 20;12(5):e1006051. doi: 10.1371/journal.pgen.1006051. eCollection 2016 May.
5
The Hepatitis Viral Status in Patients With Hepatocellular Carcinoma: a Study of 3843 Patients From Taiwan Liver Cancer Network.肝细胞癌患者的肝炎病毒状态:对台湾肝癌网络3843例患者的研究
Medicine (Baltimore). 2016 Apr;95(15):e3284. doi: 10.1097/MD.0000000000003284.
6
Methylation-regulated miR-124-1 suppresses tumorigenesis in hepatocellular carcinoma by targeting CASC3.甲基化调控的miR-124-1通过靶向CASC3抑制肝细胞癌的肿瘤发生。
Oncotarget. 2016 May 3;7(18):26027-41. doi: 10.18632/oncotarget.8266.
7
Nitric oxide in liver diseases.肝脏疾病中的一氧化氮
Trends Pharmacol Sci. 2015 Aug;36(8):524-36. doi: 10.1016/j.tips.2015.05.001. Epub 2015 May 28.
8
Hepatocarcinogenesis driven by GSNOR deficiency is prevented by iNOS inhibition.GSNOR 缺陷导致的肝癌发生可被 iNOS 抑制所阻断。
Cancer Res. 2013 May 1;73(9):2897-904. doi: 10.1158/0008-5472.CAN-12-3980. Epub 2013 Feb 25.
9
S-nitrosoglutathione reductase deficiency increases mutagenesis from alkylation in mouse liver.S-亚硝基谷胱甘肽还原酶缺乏增加了小鼠肝脏烷化作用的突变率。
Carcinogenesis. 2013 May;34(5):984-9. doi: 10.1093/carcin/bgt031. Epub 2013 Jan 25.
10
Analysis of genetic damage and gene polymorphism in hepatocellular carcinoma (HCC) patients in a South Indian population.分析印度南部人群原发性肝癌患者的遗传损伤和基因多态性。
Dig Dis Sci. 2013 Mar;58(3):759-67. doi: 10.1007/s10620-012-2409-8. Epub 2012 Oct 2.